"Ciprofloxacin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A broad-spectrum antimicrobial carboxyfluoroquinoline.
| Descriptor ID |
D002939
|
| MeSH Number(s) |
D03.633.100.810.835.322.186
|
| Concept/Terms |
Ciprofloxacin Hydrochloride- Ciprofloxacin Hydrochloride
- Hydrochloride, Ciprofloxacin
- Ciprofloxacin Monohydrochloride Monohydrate
- Monohydrate, Ciprofloxacin Monohydrochloride
- Monohydrochloride Monohydrate, Ciprofloxacin
|
Below are MeSH descriptors whose meaning is more general than "Ciprofloxacin".
Below are MeSH descriptors whose meaning is more specific than "Ciprofloxacin".
This graph shows the total number of publications written about "Ciprofloxacin" by people in this website by year, and whether "Ciprofloxacin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 1 | 2 |
| 1997 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2010 | 1 | 1 | 2 |
| 2015 | 1 | 1 | 2 |
| 2016 | 1 | 1 | 2 |
| 2019 | 1 | 1 | 2 |
| 2020 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ciprofloxacin" by people in Profiles.
-
Necrotizing Otitis Externa: A Systematic Review and Analysis of Changing Trends. Otol Neurotol. 2020 09; 41(8):1004-1011.
-
Response to: letter to the editor: consideration on 'an evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the food and drug administration and the European medicines agency' by bennett et al. Expert Opin Drug Saf. 2020 08; 19(8):1057-1058.
-
An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin-association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency. Expert Opin Drug Saf. 2019 Nov; 18(11):1055-1063.
-
Disseminated Cryptococcus neoformans infection in a left ventricular assist device recipient. BMJ Case Rep. 2019 Apr 08; 12(4).
-
Susceptibility of Multidrug-Resistant Gram-Negative Urine Isolates to Oral Antibiotics. Antimicrob Agents Chemother. 2016 05; 60(5):3138-40.
-
Alteration of the Disposition of Quinine in Healthy Volunteers After Concurrent Ciprofloxacin Administration. Am J Ther. 2016 Mar-Apr; 23(2):e398-404.
-
Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates. Int J Antimicrob Agents. 2015 Dec; 46(6):642-7.
-
Impact of a Stewardship-Initiated Restriction on Empirical Use of Ciprofloxacin on Nonsusceptibility of Escherichia coli Urinary Isolates to Ciprofloxacin. Pharmacotherapy. 2015 May; 35(5):464-9.
-
Efficacy and safety of ciprofloxacin for prophylaxis of polyomavirus BK virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant. 2011 Aug; 17(8):1176-81.
-
Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE. Support Care Cancer. 2010 Feb; 19(2):231-7.